MuSK (Muscle Specific Kinase) positive myasthenia: Grave prognosis or undue prejudice?
Objectives: Patients with muscle-specific kinase (MuSK)-positive myasthenia are generally considered to have a grave prognosis. We present our experience of patients with myasthenia with different antibody status. This is followed by a short discourse on previous studies and the current view on MuSK...
Main Authors: | Priyanka Samal, Vinay Goyal, Mamta B Singh, M V Padma Srivastava |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Annals of Indian Academy of Neurology |
Subjects: | |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2020;volume=23;issue=1;spage=32;epage=37;aulast=Samal |
Similar Items
-
Anti-MuSK antibody positive myasthenia gravis with childhood onset
by: Diana Epure, et al.
Published: (2016-06-01) -
Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
by: Yung-Chuan Huang, et al.
Published: (2008-07-01) -
MuSK Myasthenia Gravis—Potential Pathomechanisms and Treatment Directed against Specific Targets
by: Edyta Dziadkowiak, et al.
Published: (2024-03-01) -
Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
by: Amber Eker, et al.
Published: (2020-08-01) -
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis
by: Mariapaola Marino, et al.
Published: (2020-05-01)